UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

Gut, 2003-09, Vol.52 (9), p.1347-1354

2003

Volltextzugriff (PDF)

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

British journal of cancer, 2001-08, Vol.85 (4), p.584-589

2001

Volltextzugriff (PDF)

Complete and Specific Inhibition of Adult Lymphatic Regeneration by a Novel VEGFR-3 Neutralizing Antibody

JNCI : Journal of the National Cancer Institute, 2005-01, Vol.97 (1), p.14-21

2005

Volltextzugriff (PDF)

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors

Cancer research (Chicago, Ill.), 1999-10, Vol.59 (20), p.5209-5218

1999

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms

Clinical cancer research, 2000-05, Vol.6 (5), p.1936-1948

2000

Volltextzugriff (PDF)

Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice

Clinical cancer research, 1999-02, Vol.5 (2), p.257-265

1999

Volltextzugriff (PDF)

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

European journal of cancer (1990), 2002-05, Vol.38 (8), p.1133-1140

2002

Volltextzugriff (PDF)

Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

Clinical cancer research, 2000-12, Vol.6 (12), p.4874-4884

2000

Volltextzugriff (PDF)

Down-Regulation of HLA Class I Antigen-Processing Molecules in Malignant Melanoma : Association with Disease Progression

The American journal of pathology, 1999-03, Vol.154 (3), p.745-754

1999

Volltextzugriff (PDF)

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice

Clinical cancer research, 1998-12, Vol.4 (12), p.2957-2966

1998

Volltextzugriff (PDF)

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases

Cancer, 2000-08, Vol.89 (3), p.488-499

2000

Volltextzugriff (PDF)

Epidermal growth factor receptor blockade by antibody IMC‐C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice

Cancer, 2000-07, Vol.89 (1), p.74-82

2000

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Levels and Induction of Permeability in Malignant Pleural Effusions

Clinical cancer research, 1999-11, Vol.5 (11), p.3364-3368

1999

Volltextzugriff (PDF)

Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel

Clinical cancer research, 2000-07, Vol.6 (7), p.2635-2643

2000

Volltextzugriff (PDF)

Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells

British journal of cancer, 2003-03, Vol.88 (5), p.796-802

2003

Volltextzugriff (PDF)

Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4556-4560

2000

Volltextzugriff (PDF)

Effect of platelet-derived growth factor on tibial osteotomies in rabbits

Bone (New York, N.Y.), 1994-03, Vol.15 (2), p.203-208

1994

Volltextzugriff (PDF)

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis

Cancer cell, 2005, Vol.7 (1), p.101-111

2005

Volltextzugriff (PDF)

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

Oncogene, 2005-04, Vol.24 (16), p.2647-2653

2005

Volltextzugriff (PDF)

Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils

The FASEB journal, 2005-12, Vol.19 (14), p.2005-2007

2005

Volltextzugriff (PDF)

VEGF receptor 2 blockade leads to renal cyst formation in mice

Kidney international, 2006-05, Vol.69 (10), p.1741-1748

2006

Volltextzugriff (PDF)

HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions

Cancer research (Chicago, Ill.), 1998-02, Vol.58 (4), p.737-742

1998

Volltextzugriff (PDF)

Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors

Blood, 2000-02, Vol.95 (3), p.952-958

2000

Volltextzugriff (PDF)

Effect of p53 Status on Tumor Response to Antiangiogenic Therapy

Science (American Association for the Advancement of Science), 2002-02, Vol.295 (5559), p.1526-1528

2002

Volltextzugriff (PDF)

KDR/Flk‐1 is a major regulator of vascular endothelial growth factor–induced tumor development and angiogenesis in murine hepatocellular carcinoma cells

Hepatology (Baltimore, Md.), 1999-11, Vol.30 (5), p.1179-1186

1999

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(182)

Publikationsform

Artikel
(217)
Tagungsberichte
(1)

Sprache

Englisch
(218)
Japanisch
(57)

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(155)
Humans
(125)
Animals
(116)
Mice
(101)
Biological And Medical Sciences
(91)
Medical Sciences
(81)
Oncology
(69)
Female
(55)
Male
(50)
Tumors
(47)
Antineoplastic Agents
(40)
Pharmacology. Drug Treatments
(40)
Mice, Nude
(35)
Antibodies, Monoclonal - Pharmacology
(34)
Angiogenesis
(33)
Tumor Cells, Cultured
(31)
Receptors, Vascular Endothelial Growth Factor
(29)
Antibodies, Monoclonal - Therapeutic Use
(26)
Neoplasm Transplantation
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

Complete and Specific Inhibition of Adult Lymphatic Regeneration by a Novel VEGFR-3 Neutralizing Antibody

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors

Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms

Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

Down-Regulation of HLA Class I Antigen-Processing Molecules in Malignant Melanoma : Association with Disease Progression

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases

Epidermal growth factor receptor blockade by antibody IMC‐C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice

Vascular Endothelial Growth Factor Levels and Induction of Permeability in Malignant Pleural Effusions

Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel

Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells

Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy

Effect of platelet-derived growth factor on tibial osteotomies in rabbits

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils

VEGF receptor 2 blockade leads to renal cyst formation in mice

HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions

Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors

Effect of p53 Status on Tumor Response to Antiangiogenic Therapy

KDR/Flk‐1 is a major regulator of vascular endothelial growth factor–induced tumor development and angiogenesis in murine hepatocellular carcinoma cells

Suchergebnisse filtern